Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
10.02
-0.78 (-7.22%)
At close: May 28, 2025, 4:00 PM
10.07
+0.05 (0.50%)
After-hours: May 28, 2025, 4:04 PM EDT

Pharming Group Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Pharming Group stock ranges from a low of $14 to a high of $39. The average analyst price target of $30 forecasts a 199.40% increase in the stock price over the next year.

Price Target: $30.00 (+199.40%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $14 $30 $37 $39
Change +39.72% +199.40% +269.26% +289.22%
* Price targets were last updated on Mar 21, 2025.

Analyst Ratings

The average analyst rating for Pharming Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 222222
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 333333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$37
Strong Buy Reiterates $37 +269.26% Mar 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$37
Strong Buy Reiterates $37 +269.26% Mar 20, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$30$39
Buy Maintains $30$39 +289.22% Mar 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$37
Strong Buy Reiterates $37 +269.26% Mar 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$37
Strong Buy Reiterates $37 +269.26% Dec 17, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
336.76M
from 297.20M
Increased by 13.31%
Revenue Next Year
362.61M
from 336.76M
Increased by 7.68%
EPS This Year
0.02
from -0.02
EPS Next Year
-0.02
from 0.02
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
212.17M198.87M205.62M245.32M297.20M336.76M362.61M394.58M
Revenue Growth
12.03%-6.27%3.40%19.30%21.15%13.31%7.68%8.82%
EPS
0.050.020.02-0.02-0.020.02-0.020.03
EPS Growth
-9.84%-58.18%-17.39%-----
Forward PE
-----502.49-374.16
No. Analysts
-----988
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 353.1M 408.9M 468.6M
Avg 336.8M 362.6M 394.6M
Low 305.8M 306.5M 266.3M

Revenue Growth

Revenue Growth 20252026202720282029
High
18.8%
21.4%
29.2%
Avg
13.3%
7.7%
8.8%
Low
2.9%
-9.0%
-26.6%

EPS Forecast

EPS 20252026202720282029
High 0.16 0.02 0.07
Avg 0.02 -0.02 0.03
Low -0.04 -0.06 -

EPS Growth

EPS Growth 20252026202720282029
High -
-10.5%
-
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.